| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. | J Allergy Clin Immunol | 1998 | 1.52 |
| 2 | Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients. | J Allergy Clin Immunol | 1991 | 1.16 |
| 3 | Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. | J Allergy Clin Immunol | 1992 | 0.97 |
| 4 | Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy. | J Allergy Clin Immunol | 2001 | 0.90 |
| 5 | Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom. | Allergy | 1989 | 0.86 |
| 6 | Mastocytosis and atopy: a study of 33 patients with urticaria pigmentosa. | Allergy | 1990 | 0.84 |